97 related articles for article (PubMed ID: 2554350)
1. High affinity binding of the calcium channel blocker, (+)-[methyl-3H]PN200-110(3HPN) in rat brain.
Magill SB; Stone JS; Parmar SS
Physiol Behav; 1989 Jul; 46(1):101-4. PubMed ID: 2554350
[TBL] [Abstract][Full Text] [Related]
2. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
Murphy BJ; Rogers CA; Sunahara RK; Lemaire S; Tuana BS
Mol Pharmacol; 1990 Feb; 37(2):173-81. PubMed ID: 2154669
[TBL] [Abstract][Full Text] [Related]
3. Relationship of dihydropyridine binding sites with calcium-dependent neurotransmitter release in synaptosomes.
Massieu L; Tapia R
J Neurochem; 1988 Oct; 51(4):1184-9. PubMed ID: 2458434
[TBL] [Abstract][Full Text] [Related]
4. Characterization of 1,4, dihydropyridine calcium channel binding sites in the human prostate.
Rosenthal E; Shapiro E; Lepor H
J Urol; 1990 Dec; 144(6):1539-42. PubMed ID: 1700163
[TBL] [Abstract][Full Text] [Related]
5. Low dihydropyridine receptor density in vasa deferentia of castrated rats.
Castillo CJ; Lafayette S; Caricati-Neto A; Sette M; Jurkiewicz NH; García AG; Jurkiewicz A
Br J Pharmacol; 1992 Feb; 105(2):257-8. PubMed ID: 1313721
[TBL] [Abstract][Full Text] [Related]
6. Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance.
Yaney GC; Stafford GA; Henstenberg JD; Sharp GW; Weiland GA
J Pharmacol Exp Ther; 1991 Aug; 258(2):652-62. PubMed ID: 1713965
[TBL] [Abstract][Full Text] [Related]
7. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
Lee HR; Roeske WR; Yamamura HI
Life Sci; 1984 Aug; 35(7):721-32. PubMed ID: 6088927
[TBL] [Abstract][Full Text] [Related]
8. Thermodynamic and kinetic aspects of agonist and antagonist binding to 1,4-dihydropyridine receptors.
Zheng W; Hawthorn M; Triggle DJ
Eur J Pharmacol; 1991 Oct; 208(2):137-47. PubMed ID: 1724760
[TBL] [Abstract][Full Text] [Related]
9. A new class of calcium entry blockers defined by 1,3-diphosphonates. Interactions of SR-7037 (belfosdil) with receptors for calcium channel ligands.
Rossier JR; Cox JA; Niesor EJ; Bentzen CL
J Biol Chem; 1989 Oct; 264(28):16598-607. PubMed ID: 2550449
[TBL] [Abstract][Full Text] [Related]
10. Interaction of pinaverium (a quaternary ammonium compound) with 1,4-dihydropyridine binding sites in rat ileum smooth muscle.
Feron O; Wibo M; Christen MO; Godfraind T
Br J Pharmacol; 1992 Feb; 105(2):480-4. PubMed ID: 1313732
[TBL] [Abstract][Full Text] [Related]
11. Binding Ca2+ to intracellular or to extracellular sites of dihydropyridine receptor of rabbit skeletal muscle discriminates between in vitro binding of Ca2+-channel agonist and antagonist.
Kanngiesser U; Pongs O
Eur J Biochem; 1989 May; 181(2):467-73. PubMed ID: 2540975
[TBL] [Abstract][Full Text] [Related]
12. Dihydropyridine [methyl-3H]PN 200-110 binding and myogenesis in intact muscle cells in vitro.
Navarro J
J Neurochem; 1986 Apr; 46(4):1166-9. PubMed ID: 3005507
[TBL] [Abstract][Full Text] [Related]
13. Relaxation of potassium chloride-induced contractions by amlodipine and its interaction with the 1,4-dihydropyridine-binding site in pig coronary artery.
Matlib MA
Am J Cardiol; 1989 Nov; 64(17):51I-57I. PubMed ID: 2530885
[TBL] [Abstract][Full Text] [Related]
14. Novel interactions of cations with dihydropyridine calcium antagonist binding sites in brain.
Bolger GT; Skolnick P
Br J Pharmacol; 1986 Aug; 88(4):857-66. PubMed ID: 3017494
[TBL] [Abstract][Full Text] [Related]
15. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
Nokin P; Clinet M; Beaufort P; Meysmans L; Laruel R; Chatelain P
J Pharmacol Exp Ther; 1990 Nov; 255(2):600-7. PubMed ID: 2147036
[TBL] [Abstract][Full Text] [Related]
16. Residual inhibition in density of [3H]isradipine binding sites in rat brain membrane pretreated with amlodipine.
Qu YL; Takamizawa C; Sugiyama K; Maruyama K; Hattori K; Watanabe K; Nagatomo T
Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):289-93. PubMed ID: 7668092
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of binding of dihydropyridine calcium channel blockers to rat brain membranes.
Weiland GA; Oswald RE
J Biol Chem; 1985 Jul; 260(14):8456-64. PubMed ID: 3159733
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the dihydropyridine binding sites of rat neocortical synaptosomes and microvessels.
Dooley DJ; Mählmann H; Brenner O; Osswald H
J Neurochem; 1987 Sep; 49(3):900-4. PubMed ID: 3039058
[TBL] [Abstract][Full Text] [Related]
19. Multiple calcium channels in synaptosomes: voltage dependence of 1,4-dihydropyridine binding and effects on function.
Dunn SM
Biochemistry; 1988 Jul; 27(14):5275-81. PubMed ID: 2458759
[TBL] [Abstract][Full Text] [Related]
20. Voltage-sensitive Ca2+ channels involved in nicotinic receptor-mediated [3H]dopamine release from rat striatal synaptosomes.
Soliakov L; Wonnacott S
J Neurochem; 1996 Jul; 67(1):163-70. PubMed ID: 8666987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
